Ashton Thomas Private Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,578
Closed -$179K 952
2024
Q2
$179K Sell
1,578
-140
-8% -$17.7K 0.01% 589
2024
Q1
$238K Sell
1,718
-220
-11% -$27.7K 0.01% 537
2023
Q4
$240K Buy
+1,938
New +$198K 0.02% 531
2023
Q3
Sell
-1,937
Closed -$249K 575
2023
Q2
$249K Buy
+1,937
New +$234K 0.02% 518
2022
Q2
Sell
-2,340
Closed -$299K 456
2022
Q1
$299K Buy
+2,340
New +$256K 0.03% 410

Other funds holding DXCM

Ashton Thomas Private Wealth's DXCM Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,578 shares — an estimated $179K sold.

Ashton Thomas Private Wealth first reported a position in DXCM in Q1 2022 and held it in 5 quarters. The position peaked at $299K in Q1 2022. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 1,578 DexCom shares in Q3 2024, an estimated $179K.
  • Ashton Thomas Private Wealth first reported a position in DexCom in Q1 2022 and held it in 5 quarters.
  • Ashton Thomas Private Wealth's DexCom position peaked at $299K in Q1 2022.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.